With many anti-cancer drugs taken orally, it's up to patients to comply with prescribed regimens — but what happens if they don't?
Susan Jenks
Advertisement
Articles by Susan Jenks
Biomarker research paves the way to precision cancer medicine.
People with cancer should ask questions about what biomarker tests are offered for their cancer type, what those tests offer and what they don't.
A new law hopes to speed drug development for therapies in the age of biomarker-driven treatment.
The cancer organization proposes new screening guidelines for lung cancer.
Advertisement
Latest Updated Articles
Personalized Medicine Revolution Gains MomentumPublished: March 4th 2014 | Updated:
What You Need to Know About Biomarker TestingPublished: March 3rd 2014 | Updated:
- ACS Proposes New Lung Cancer Screening Guidelines
Published: March 13th 2013 | Updated:
- FDA's Breakthrough Therapy Designation Aims to Speed Drug Approvals
Published: December 8th 2013 | Updated:
- The Best Laid Plans
Published: June 15th 2015 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Breast Cancer Awareness Month Spotlights Reconstruction Access
2
Helping Patients Understand the Evolving Landscape of Kidney Cancer Treatment
3
Navigating My Breast Cancer Treatment Decisions at 39
4
What Newly Diagnosed Patients Need to Know About Stage 2 Melanoma
5
